PCI 7 November 2023, 15:44
Temax_Krautz
Owen Mumford 12 January 2022, 17:40

Current Edition

Nasal & Pulmonary Drug Development
Staubli 11 March 2024, 13:59
Catalent: Mon 28 October 2024, 13:21
Novo Nordisk 20 March 2024, 11:21
Schott: Tue 17 September 2024, 10:51
Biosynth: Fri 4 October 2024, 10:42
Developing Healthcare Facilities
Regulatory & Marketplace V6I4

Developing Healthcare Facilities

If you are the operator of a nursing or care home, and you are considering commissioning the building of a new care or nursing home, or extending or refurbishing an ...
Continue Reading →
ISO IDMP – Four Challenges in Preparing Organisations for the July 1, 2016 EMA Deadline
Regulatory & Marketplace V6I4

ISO IDMP – Four Challenges in Preparing Organisations for the July 1, 2016 EMA Deadline

Most pharmaceutical companies face challenges in becoming compliant with the ISO IDMP standards. In this article, Rune Bergendorff, responsible for NNIT’s ISO IDMP s...
Continue Reading →
Regulatory & Marketplace V6I4

How Much Data Should You Include in a Patent Application?

In the life sciences and chemistry fields it is important to be aware that a perceived lack of data in a patent application can have an impact on the eventual scope ...
Continue Reading →
A Hard Pill to Swallow: Meeting the Needs of Modern Consumers
Regulatory & Marketplace V6I4

A Hard Pill to Swallow: Meeting the Needs of Modern Consumers

Confronted with the “patent cliff”, dwindling drug discovery success and a host of other challenges, pharmaceutical companies are being forced to reconsider how they...
Continue Reading →
Cost Savings for Healthcare Estates: Delivered through Improved Waste Management
Regulatory & Marketplace V6I4

Cost Savings for Healthcare Estates: Delivered through Improved Waste Management

You only have to read a newspaper or turn on the news to see how the NHS is struggling to meet the balance between demand for healthcare services and funding. Tony M...
Continue Reading →
“Personal Pill” Regulations: Current Landscape and Future Scenario
Regulatory & Marketplace V6I4

“Personal Pill” Regulations: Current Landscape and Future Scenario

The rapidly-evolving science of pharmacogenetics brought in the amazing concept of “personalisation of medicines” also referred to as the “personal pill”. Balamurali...
Continue Reading →
SAE Media: Fri 25 October 2024, 10:33
PHARMAP: Mon 14 October 2024, 10.36
Automa: Mon 14 October 2024, 10:22
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Stoelzle Skyscraper: 27th November 2024
LBBOHLE, Thu 20 April 2023, 17:23
Nipro 14 March 2024, 11:35
Novonordisk: Wed 17 July 2024, 13:49